[The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients]

Junqing Xu1, Zefeng Xu, Jingya Wang

  • 1Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC. The State Key Laboratory of Experimental Hematology, Tianjin 300020, China.

Abstract

Related Concept Videos